Vnitr Lek 2013, 59(7):587-590

Hepatic vein catheterisation - selected assessment aspects

J. Petrtýl1,*, R. Brůha1, P. Urbánek2, Z. Mareček3, M. Kaláb1
1 IV. interní klinika 1. lékařské fakulty UK a VFN Praha, přednosta prof. MUDr. Aleš Žák, DrSc.
2 Interní klinika 1. lékařské fakulty UK a ÚVN Praha, přednosta prof. MUDr. Miroslav Zavoral, Ph.D.
3 KlinMed s.r.o., Praha, vedoucí prof. MUDr. Zdeněk Mareček, DrSc.

Introduction:
Hepatic vein catheterisation and portal hypertension assessment using the value of portal hepatic gradient (HVPG) is currently a method of choice.

Methodology:
In our paper we shall compare HVPG with the so-called direct gradient - using the difference in pressure in the portal vein and free hepatic vein in 5 groups of patients with liver cirrhosis.

Results:
Hepatic vein catheterisation is reliable for assessing the portal hypertension in the group of patients with liver cirrhosis of ethylic etiology. In patients with liver cirrhosis resulting from hepatitis B, Wilson's disease or primary biliary cirrhosis, a statistically significant difference between HVPG and the direct gradient has been found. In patients with liver cirrhosis resulting from hepatitis C the obtained values differed but without statistical significance.

Conclusion:
In catheterisation of hepatic veins the HVPG value in liver cirrhosis with a presinusoidal component may be reduced, which has to be primarily taken into account when assessing the relationship to some critical values of the portal hepatic gradient.

Keywords: portal hypertension; hepatic vein catheterisation; liver cirrhosis; portal hepatic gradient

Received: May 8, 2013; Published: July 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Petrtýl J, Brůha R, Urbánek P, Mareček Z, Kaláb M. Hepatic vein catheterisation - selected assessment aspects. Vnitr Lek. 2013;59(7):587-590.
Download citation

References

  1. Bosch J, García-Pagán JC. Complication of cirrhosis. I. Portal hypertension. J Hepatol 2000; 32 (Suppl 1): 141-156. Go to original source... Go to PubMed...
  2. van Leeuwen DJ, Howe SC, Scheuer PJ et al. Portal hypertesion in chronic hepatitis: relationship to morphological changes. Gut 1990; 31: 339-343. Go to original source... Go to PubMed...
  3. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000; 33: 846-852. Go to original source... Go to PubMed...
  4. Garcia-Tsao G, Groszmann RJ, Fisher RL et al. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985; 5: 419-424. Go to original source... Go to PubMed...
  5. Feu F, García-Pagán JC, Bosch J et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal hemorrhage in patients with cirrhosis. Lancet 1995; 346: 1056-1059. Go to original source... Go to PubMed...
  6. Zipprich A, Winkler M, Seufferlein T et al. Comparison of balloon vs. straight catheter for the measurement of portal hypertension. Aliment Pharmacol Ther 2010; 32: 1351-1356. Go to original source... Go to PubMed...
  7. Keiding S, Vilstrup H. Intrahepatic heterogeneity of hepatic venous pressure gradient in human cirrhosis. Scand J Gastroenterol 2002; 37: 960-964. Go to original source... Go to PubMed...
  8. Bosch J, Mastai R, Kravetz D et al. Hemodynamic evaluation of the patient with portal hypertension. Semin Liver Dis 1986; 6: 309-317. Go to original source... Go to PubMed...
  9. Sarin SK, Sethi KK, Nanda R. Measurement and correlation of wedged hepatic intrahepatic, intrasplenic and intravariceal pressures in patients with cirrhosis of liver and non-cirrhotic portal fibrosis. Gut 1987; 28: 260-266. Go to original source... Go to PubMed...
  10. Lebrec D, Benhamou JP. Noncirrhotic intrahepatic portal hypertension. Semin Liver Dis 1986; 6: 332-340. Go to original source... Go to PubMed...
  11. van Leeuwen DJ. Assessment of portal hypertension: understanding will improve treatment. Dig Dis 1991; 9: 92-105. Go to original source... Go to PubMed...
  12. Deplano A, Migaleddu V, Pischedda A et al. Portohepatic gradient and portal hemodynamics in patients with cirrhosis due to hepatitis C virus infection. Dig Dis Sci 1999; 44: 155-162. Go to original source... Go to PubMed...
  13. Patch D, Armonis A, Sabin C et al. Single portal measurement predicts survival in cirrhotic patients with recent bleeding. Gut 1999; 44: 264-269. Go to original source... Go to PubMed...
  14. Moitinho E, Escorsell A, Bandi JC et al. Prognostic value of early measurement of portal pressure in acute variceal bleeding. Gastroenterology 1999; 117: 626-631. Go to original source... Go to PubMed...
  15. Albillos A, Bañares R, Gonzáles M et al. Value of the hepatic venous pressure gradient to monitor drug therapy for portal hypertension: a meta-analysis. Am J Gastroenterol 2007; 102: 1116-1126. Go to original source... Go to PubMed...
  16. Villanueva C, Aracil C, Colomo A et al. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding. Gastroenterology 2009; 137: 119-128. Go to original source... Go to PubMed...
  17. Abraldes JG, Villanueva C, Bañares R et al. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol 2008; 48: 229-236. Go to original source... Go to PubMed...
  18. Ripoll C, Groszmann R, Garcia-Tsao G et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gaastroenterology 2007; 133: 481-488. Go to original source... Go to PubMed...
  19. Triantos CK, Nikolopoulou V, Burroughs AK. Review article: the therapeutic and prognostic benefit of portal pressure reduction in cirrhosis. Aliment Pharmacol Ther 2008; 28: 943-952. Go to original source... Go to PubMed...
  20. de Franchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010; 53: 762-768. Go to original source... Go to PubMed...
  21. Raia S, Mies S, Macedo AL. Portal hypertension in schistosomiasis. Clin Gastroenterol 1985; 14: 57-82. Go to original source... Go to PubMed...
  22. Molina EG, Amaro R, Ness J et al. Change in Child's score does not predict progression in size of esophageal varices. Hepatology 1999; 30: 577A.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.